Decreased Psoas Muscle Area is a Prognosticator for 90-Day and 1-Year Survival in Patients Undergoing Surgical Treatment for Spinal Metastasis

Survival estimation for patients with spinal metastasis is crucial to treatment decisions. Psoas muscle area (PMA), a surrogate for total muscle mass, has been proposed as a useful survival prognosticator. However, few studies have validated the predictive value of decreased PMA in an Asian cohort or its predictive value after controlling for existing preoperative scoring systems (PSSs). In this study, we aim to answer: (1) Is PMA associated with survival in Han Chinese patients with spinal metastasis? (2) Is PMA a good prognosticator according to concordance index (c-index) and decision curve analysis (DCA) after controlling for six existing and commonly used PSSs?

Go to Source

This article was first shared by INDoximity

This article was first shared by INDoximity:

You may also like...

Enable Notifications    OK No thanks